Skip to main content

Klinisch-chemische Diagnostik der Myokardschädigung

  • Chapter
HerzAkutMedizin
  • 861 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 2.2

  1. Adams III JE, Abendschein DR, Jaffe AS (1993) Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 88:750–763

    PubMed  CAS  Google Scholar 

  2. Apple FS, Wu AHB, Jaffe AS (2002) European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. J Am Heart 144:981–986

    Article  Google Scholar 

  3. Apple, SF, Quist HD, Doyle PJ, Otto AP, Murakami MM (2003) Plasma 99th percentile reference limits for troponin and creatine cinase MB mass for use with European Society of Cardiology/American College of Cardiology Consensus Recommendations. Clin Chem 49:1331–1336

    Article  PubMed  CAS  Google Scholar 

  4. Bhayana V, Henderson AR (1995) Biochemical markers of myocardial damage. Clinical Biochemistry 28:1–29

    Article  PubMed  CAS  Google Scholar 

  5. Bundesärztekammer (2001) Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Beschluss des Vorstandes der Bundesärztekammer vom 24. August 2001. Dtsch Arztebl 98:A2747–2759

    Google Scholar 

  6. Bundesärztekammer (2002) Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Änderung durch Beschluss des Vorstandes der Bundesärztekammer vom 22. März 2002. Dtsch Ärztebl 99:A1187

    Google Scholar 

  7. Davis GK (2003) Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty. Scand J Clin Lab Invest 63:167–174

    Article  PubMed  CAS  Google Scholar 

  8. Panteghini M (2002) Acute coronary syndrom. Biochemical strategies in the troponin era. Chest 122:1428–1435

    Article  PubMed  CAS  Google Scholar 

  9. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, Mair J, Ravkilde J, Wu AH (2004) Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 50:327–332

    Article  PubMed  CAS  Google Scholar 

  10. Schumann G (2003) International standardisierte Enzymmethoden im klinischen Routinelabor. DGKC Mitteilungen 1:6–10

    Google Scholar 

  11. The Joint European Society of Cardiology/ American College of Cardiology Committee for Redifinition of Myocardial Infarction (2000) Myocardial infarction redefined — a consensus document of the Join European Society of Cardiology/American College of Cardiology Committee for Redifinition of Myocardial Infarction. Eur Heart J 21:1502–1513

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Schimke, I. (2006). Klinisch-chemische Diagnostik der Myokardschädigung. In: Zerkowski, H.R., Baumann, G. (eds) HerzAkutMedizin. Steinkopff. https://doi.org/10.1007/3-7985-1630-8_15

Download citation

  • DOI: https://doi.org/10.1007/3-7985-1630-8_15

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1505-5

  • Online ISBN: 978-3-7985-1630-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics